Literature DB >> 11818172

Persistent cognitive impairment following surgical treatment of Cushing's syndrome.

Hélène Forget1, André Lacroix, Henri Cohen.   

Abstract

Chronic exposure to elevated glucocorticoid (GC) levels in Cushing's syndrome (CS) is associated with deficits in cognitive function. It has already been shown that CS patients scored significantly lower than controls on several aspects of cognitive function (J. Int. Neuropsychol. Soc. 6 (2000) 20). In the present study, 13 subjects who presented with CS were investigated one year after surgical treatment to determine the extent to which the effects of hypercortisolism on cognitive function are reversible. Subjects were evaluated with a battery of tasks, similar to the original battery of a year earlier and including tests of attention, visuospatial processing, memory, reasoning and verbal fluency. Except for one task of visual organization, the results showed little change in performance, suggesting that prolonged exposure to high levels of GC can cause long-lasting deleterious effects on cognitive function. The data suggest that correction of hypercortisolism is not necessarily correlated with short-term improvement in cognitive function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818172     DOI: 10.1016/s0306-4530(01)00059-2

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  27 in total

1.  Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients.

Authors:  M Iacobone; F Mantero; S M Basso; F Lumachi; G Favia
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

2.  Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers.

Authors:  F C Hsu; M J Garside; A E Massey; R H McAllister-Williams
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

Review 3.  Steroid psychosis: a review for neurosurgeons.

Authors:  Donald A Ross; Justin S Cetas
Journal:  J Neurooncol       Date:  2012-07-05       Impact factor: 4.130

Review 4.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

5.  Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.

Authors:  T Psaras; M Milian; V Hattermann; B E Will; M Tatagiba; J Honegger
Journal:  J Endocrinol Invest       Date:  2010-11-08       Impact factor: 4.256

6.  Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease.

Authors:  Steven J A van der Werff; J Nienke Pannekoek; Cornelie D Andela; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

7.  Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study.

Authors:  Margaret F Keil; Deborah P Merke; Roma Gandhi; Edythe A Wiggs; Kathy Obunse; Constantine A Stratakis
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-17       Impact factor: 3.478

Review 8.  Psychosomatic aspects of Cushing's syndrome.

Authors:  Nicoletta Sonino; Francesco Fallo; Giovanni A Fava
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 9.  Cushing's disease: the burden of illness.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Chiara Simeoli; Annamaria Colao
Journal:  Endocrine       Date:  2016-05-17       Impact factor: 3.633

10.  [Cognitive impairment after accidental high-dose corticosteroid therapy].

Authors:  M Arndt; H J Kunert; H Sass; C Norra
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.